Space Station Uses NemaFlex
Loss of muscle mass and strength present a major challenge for astronauts on future long space voyages. Determining Muscle Strength in Space
top of page
- Sep 27, 2022
NemaLife receives funding to develop a neurotherapeutic discovery platform
NemaLife receives funding to develop a neurotherapeutic discovery platform using next-generation psychedelic compounds. LUBBOCK, TX, USA,...
- Sep 13, 2022
NemaLife CTO receives the prestigious REDI award from the National Institute on Aging
NemaLife’s AI-assisted microfluidics-based tech platform receives funding to pursue rapid discovery of drug candidates that could improve...
- Jul 12, 2022
BioSpace Article - Worms: They’re a Lot Like Us, and that’s Good for Drug Development
To most, roundworms, or C. elegans, are just that: microscopic worms that live beneath our feet in the soil. But to scientists and...
- Jun 13, 2022
Google Interviews the NemaLife Team
Worms in the Cloud: How nematodes and AI are transforming R&D NemaLife is using AI and Cloud to drive faster, lower cost...
- May 4, 2022
Motif FoodWorks Announces Strategic Investment in NemaLife, Inc.
The collaboration will support Motif's rapid food-technology product pipeline by utilizing in vivo testing for functional properties of...
- Apr 19, 2022
DEA registered NemaLife Inc. to work with Schedule 1 substances
NemaLife Inc., completed its DEA schedule 1 registration. If you have scheduled compounds (schedule 1-5) to test, reach out to our...
- Apr 19, 2022
NemaLife & UC Davis enter into research partnership
NemaLife and UC Davis enter into a research partnership to test the therapeutic potential of several novel psychoplastogens developed in...
- Apr 7, 2022
Artificial intelligence discovers ingredients for food, supplements
Using AI, companies survey thousands of plant compounds to quickly and automatically identify potential ingredients for use in foods and...
bottom of page